Delivery Order SPE2DB20D1100-SPE2DB25FC8P2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $21,098.76. This firm fixed-price delivery order, which has an ultimate completion date of June 3, 2025, carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a contract value of $13,351.40. The award, issued under firm fixed-price terms with no set-aside designation, represents a competitively awarded delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $1,783.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract through open competition. The order is scheduled for completion by July 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count units) with a ceiling value of $15,739.23. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Abiraterone Acetate 500 mg, valued at $7,898.12 under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 tablets of Abiraterone Acetate 250 mg, valued at $13,450.30, with an ultimate completion date of July 31, 2025. This competitive award, issued as a firm fixed-price delivery order, is being performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $1,463.13. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120 count) with a contract ceiling value of $96,424.70. This competitive award employs firm fixed pricing and requires completion by September 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC8P2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,776.45 on June 11, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 12, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order falls under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical supply vehicle enabling AmerisourceBergen to deliver medications and medical supplies supporting military healthcare programs worldwide. The abiraterone acetate delivery fulfills critical pharmaceutical needs for Defense Health Agency customers and other federal healthcare systems through this flexible contract mechanism, which provides access to a broad range of brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 6/11/25 |